Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) EBIT : R$205 Mil (TTM As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Profarma Distribuidora De Produtos Farmaceuticos EBIT?

Profarma Distribuidora De Produtos Farmaceuticos's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was R$59 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was R$205 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Profarma Distribuidora De Produtos Farmaceuticos's annualized ROC % for the quarter that ended in Dec. 2023 was 9.58%. Profarma Distribuidora De Produtos Farmaceuticos's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 15.13%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Profarma Distribuidora De Produtos Farmaceuticos's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 12.20%.

Profarma Distribuidora De Produtos Farmaceuticos EBIT Historical Data

The historical data trend for Profarma Distribuidora De Produtos Farmaceuticos's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Profarma Distribuidora De Produtos Farmaceuticos EBIT Chart

Profarma Distribuidora De Produtos Farmaceuticos Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

95.05

81.05

100.56

193.62

204.85

Profarma Distribuidora De Produtos Farmaceuticos Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT	Get a 7-Day Free Trial															27.26	18.03	57.27	70.13	59.15

Competitive Comparison of Profarma Distribuidora De Produtos Farmaceuticos's EBIT

For the Medical Distribution subindustry, Profarma Distribuidora De Produtos Farmaceuticos's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Profarma Distribuidora De Produtos Farmaceuticos's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Profarma Distribuidora De Produtos Farmaceuticos's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Profarma Distribuidora De Produtos Farmaceuticos's EV-to-EBIT falls into.

Profarma Distribuidora De Produtos Farmaceuticos EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$205 Mil.

Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Profarma Distribuidora De Produtos Farmaceuticos's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	257.456 * ( 1 - 0.72% )	/	( (2645.586	+	2688.647)	/ 2 )
=	255.6023168	/	2667.1165
=	9.58 %

where

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	4686.426	-	1861.485	-	( 179.355	-	max(0, 2425.423	-	3312.702	+	179.355	))
=	2645.586

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	4937.926	-	2055.536	-	( 193.743	-	max(0, 2446.645	-	3539.367	+	193.743	))
=	2688.647

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Profarma Distribuidora De Produtos Farmaceuticos's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	236.608	/	( ( (511.271 + max(1021.744, 0))	+	(535.59 + max(1058.089, 0)) )	/	2 )
=	236.608	/	( ( 1533.015	+	1593.679 )	/	2 )
=	236.608	/	1563.347
=	15.13 %

where Working Capital is:

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1156.917	+	1391.22	+	444.784)	-	(1861.485	+	0	+	109.692)
=	1021.744

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1187.13	+	1527.62	+	491.196)	-	(2055.536	+	0	+	92.321)
=	1058.089

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Profarma Distribuidora De Produtos Farmaceuticos's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	204.57	/	1677.036
	=	12.20 %

Profarma Distribuidora De Produtos Farmaceuticos EBIT Related Terms

Thank you for viewing the detailed overview of Profarma Distribuidora De Produtos Farmaceuticos's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Profarma Distribuidora De Produtos Farmaceuticos SA (BSP:PFRM3) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Avenida Ayrton Senna, 2.150, Bloco P, 3rd floor andar, Barra da Tijuca, RJ, BRA, 22775-900

Website

https://www.profarma.com.br

Profarma Distribuidora Produtos Farmaceuticos SA is a Brazil-based company. It is engaged in wholesale and distribution of pharmaceuticals, cosmetics and similar products, and toiletries. Profarma also holds interests in other companies, regardless of their business sector. The company through its logistics department distributes products in the South, Southeast, Northeast and Center-West regions of Brazil. The firm operates in the pharmaceutical distribution, hospital and specialty, retail segments.

Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) Headlines

No Headlines